NO964741L - Modulatorer for TNF/NGF-superfamiliereseptorer og opplöselige oligomere TNF/NGF-superfamiliereseptorer - Google Patents

Modulatorer for TNF/NGF-superfamiliereseptorer og opplöselige oligomere TNF/NGF-superfamiliereseptorer

Info

Publication number
NO964741L
NO964741L NO964741A NO964741A NO964741L NO 964741 L NO964741 L NO 964741L NO 964741 A NO964741 A NO 964741A NO 964741 A NO964741 A NO 964741A NO 964741 L NO964741 L NO 964741L
Authority
NO
Norway
Prior art keywords
tnf
superfamily receptors
ngf superfamily
modulators
ngf
Prior art date
Application number
NO964741A
Other languages
English (en)
Other versions
NO964741D0 (no
NO321514B1 (no
Inventor
David Wallach
Mark Boldin
Igor Mett
Eugene Varfolomeev
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL109632A external-priority patent/IL109632A/en
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO964741D0 publication Critical patent/NO964741D0/no
Publication of NO964741L publication Critical patent/NO964741L/no
Publication of NO321514B1 publication Critical patent/NO321514B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Transmitters (AREA)
  • Circuits Of Receivers In General (AREA)
NO19964741A 1994-05-11 1996-11-08 DNA-sekvens som koder for modulatorer for TNF/NGF superfamiliereseptorer, samt protein, farmasoytisk sammensetning, vektor, fremgangsmater og anvendelser derav. NO321514B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL109632A IL109632A (en) 1994-05-11 1994-05-11 Modulators of the function of tnf receptors
IL11112594A IL111125A0 (en) 1994-05-11 1994-10-02 Soluble oligomeric tnf/ngf super family ligand receptors and their use
PCT/US1995/005854 WO1995031544A1 (en) 1994-05-11 1995-05-11 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors

Publications (3)

Publication Number Publication Date
NO964741D0 NO964741D0 (no) 1996-11-08
NO964741L true NO964741L (no) 1997-01-09
NO321514B1 NO321514B1 (no) 2006-05-15

Family

ID=26322830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964741A NO321514B1 (no) 1994-05-11 1996-11-08 DNA-sekvens som koder for modulatorer for TNF/NGF superfamiliereseptorer, samt protein, farmasoytisk sammensetning, vektor, fremgangsmater og anvendelser derav.

Country Status (10)

Country Link
EP (1) EP0759984A4 (no)
JP (1) JP3966387B2 (no)
KR (1) KR100404737B1 (no)
CN (2) CN1329512C (no)
AU (1) AU703919B2 (no)
CA (1) CA2189983A1 (no)
FI (1) FI964509A (no)
IL (1) IL111125A0 (no)
NO (1) NO321514B1 (no)
WO (1) WO1995031544A1 (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663070A (en) * 1993-11-15 1997-09-02 Lxr Biotechnology Inc. Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM
US5712381A (en) 1994-10-19 1998-01-27 Genetics Institute, Inc. MADD, a TNF receptor death domain ligand protein
US5852173A (en) * 1994-10-19 1998-12-22 Genetics Institute, Inc. TNF receptor death ligand proteins and inhibitors of ligand binding
US5847099A (en) * 1994-10-19 1998-12-08 Genetics Institute, Inc. TNF receptor death domain ligand proteins
US5849501A (en) * 1994-10-19 1998-12-15 Genetics Institute, Inc. TNF receptor death domain ligand proteins and method to identify inhibitors of ligand binding
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6355780B1 (en) 1995-02-22 2002-03-12 Yeda Research And Development Co. Ltd. Antibodies to the death domain motifs of regulatory proteins
EP0813419B8 (en) * 1995-02-22 2005-08-24 Yeda Research & Development Company, Ltd. Modulators of regulatory proteins
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US6399327B1 (en) 1995-07-16 2002-06-04 Yeda Research And Development Co. Ltd. Modulators of the function of FAS receptors and other proteins
US6030945A (en) * 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
EP1557432B1 (en) 1996-02-20 2013-08-21 Merck Serono SA Hybrid proteins which form heterodimers
DE69733309T2 (de) * 1996-02-20 2006-01-19 Applied Research Systems Ars Holding N.V. Heterodimerebildende hybrid-proteine
WO1997037020A1 (en) 1996-04-01 1997-10-09 Genentech, Inc. Apo-2li and apo-3 apoptosis polypeptides
WO1998006839A1 (en) * 1996-07-15 1998-02-19 Human Genome Sciences, Inc. Cd44-like protein
US6462176B1 (en) 1996-09-23 2002-10-08 Genentech, Inc. Apo-3 polypeptide
CA2273185A1 (en) * 1996-11-05 1998-05-14 Board Of Regents, The University Of Texas System Compositions and uses for sentrin, a cell-death protecting protein
US6930084B1 (en) 1996-11-06 2005-08-16 The Regents Of The University Of California Treating arthritis with TNF receptor releasing enzyme
US6593456B1 (en) 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
KR100533531B1 (ko) 1996-11-06 2005-12-06 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 분리된 종양괴사인자 수용체 방출효소, 그 효소로 이루어지는 조성물 및 그것의 사용방법
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders
US6342369B1 (en) 1997-05-15 2002-01-29 Genentech, Inc. Apo-2-receptor
ATE487737T1 (de) * 1997-05-30 2010-11-15 Human Genome Sciences Inc 32 humane sekretierte proteine
US7001992B2 (en) 1997-05-30 2006-02-21 Human Genome Sciences, Inc. Antibodies to secreted protein HEMCM42
IL121746A0 (en) * 1997-06-05 1998-02-22 Yeda Res & Dev Modulators of intracellular cell death and cell survival pathways
US6051385A (en) * 1997-10-22 2000-04-18 The Regents Of The University Of Michigan Compositions and methods for identifying and testing therapeutics against HSV infection
WO1999028465A2 (en) * 1997-11-28 1999-06-10 The Regents Of The University Of California Pias molecules that recognize and bind stat proteins and uses thereof
CA2318029C (en) 1998-01-15 2009-05-19 Genentech, Inc. Apo-2 ligand
US6207422B1 (en) * 1998-04-17 2001-03-27 The Metrohealth System Protein that enhances expression of potassium channels on cell surfaces and nucleic acids that encode the same
EP1022027A1 (en) * 1999-01-22 2000-07-26 Applied Research Systems ARS Holding N.V. Tumor necrosis factor antagonists and their use in endometriosis
JP2001078776A (ja) * 1999-09-14 2001-03-27 Inst Of Physical & Chemical Res Ｎａｄｅ結合蛋白質
US9791452B2 (en) 2008-12-10 2017-10-17 Joslin Diabetes Center, Inc. Methods of diagnosing and predicting renal disease
WO2014127835A1 (en) 2013-02-22 2014-08-28 Christian-Albrechts-Universität Zu Kiel Plant-derived resistance gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP0939121B2 (de) * 1989-09-12 2007-12-26 AHP Manufacturing B.V. TFN-bindende Proteine
DE69233441T2 (de) * 1991-04-26 2005-10-13 Osaka Bioscience Institute, Suita Menschliches Zelloberflächen-Antigen codierende DNA

Also Published As

Publication number Publication date
FI964509A (fi) 1997-01-09
NO964741D0 (no) 1996-11-08
CN1173033C (zh) 2004-10-27
IL111125A0 (en) 1994-12-29
JP3966387B2 (ja) 2007-08-29
NO321514B1 (no) 2006-05-15
KR100404737B1 (ko) 2004-05-03
EP0759984A1 (en) 1997-03-05
WO1995031544A1 (en) 1995-11-23
FI964509A0 (fi) 1996-11-08
EP0759984A4 (en) 2002-06-26
JPH10500568A (ja) 1998-01-20
CN1329512C (zh) 2007-08-01
CN1616661A (zh) 2005-05-18
CN1152937A (zh) 1997-06-25
AU2546995A (en) 1995-12-05
KR970703419A (ko) 1997-07-03
CA2189983A1 (en) 1995-11-23
AU703919B2 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
NO964741L (no) Modulatorer for TNF/NGF-superfamiliereseptorer og opplöselige oligomere TNF/NGF-superfamiliereseptorer
NO964217D0 (no) Fremgangsmåte og anordning relatert til telekommunikasjonssystemer
NO981426D0 (no) Fremgangsmåte og anordning for primær-brönn-sementering
NO180552C (no) Hydraulisk utlösbar frakoplingsanordning
NO972495D0 (no) Kommunikasjonsapparat
NO980507D0 (no) Nedihullsapparat
DE69720333D1 (de) Transaktionsapparat
NO974611D0 (no) Apparat for bruk i et brönnhull
ATE170922T1 (de) Rekombinantes mistellektin (rml)
DE69628873D1 (de) Ausrichtgerät und -verfahren
NO971988D0 (no) Fremgangsmåte og anordning for telekommunikasjon
ZA953842B (en) Modulators of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
DE69622942D1 (de) Flussigkristall-anzeigvorrichtung
DK0514222T3 (da) Fremgangsmåde og apparat til kommunikation
NO964622D0 (no) Festeklemme for jernbaneskinne og anordning
NO934669D0 (no) Fremgangsmaate og anordning for sammenfoeyning
NO924872D0 (no) Fremgangsmaate og apparat til hydraulisk isolasjonsbestemmelse
DK0669535T3 (da) Fremgangsmåde og apparat til måling af den relative forskydning mellem to komponenter
NO20000653L (no) Fremgangsmåte og anordning for å bevege et stempel
NO985391D0 (no) Anordning og fremgangsmÕte relatert til telekommunikasjon
DE69609444D1 (de) Gelenkvorrichtung zum Verbinden von Armbandgliedern
GB9518522D0 (en) Bridge device
KR970045305U (ko) 액정표시장치
DK0936968T3 (da) Forbindelsesindretning og forbindelsesfremgangsmåde
NO993837L (no) FremgangsmÕte og innretning for signalmodulasjon